Yashvin Onkarappa Mangala, MD

Heme/Onc and Internal Medicine trained @RWMCIM

[Andres Gomez @GomezDLeonMD]

The 2025 ASH guidelines for older adults with AML are now out!

An honor to contribute alongside leaders in the field and to represent patients and physicians from Latin America and other LMICs.

I never imagined having the opportunity to be part of something like this! 🤯@ASH_hematology

https://t.co/iYrg0iMvzY

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

Huge thanks to the @OncBrothers for the superb ASH 2025 insights. You continue to bridge academic and community heme/onc in the best way. Grateful!

#ASH25 #HemOnc

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@VaqueraH_md Congrats, Hector!

[Héctor A. Vaquera @VaqueraH_md]

🚨New paper out🚨

Glad to have collaborated in this project where we analyzed the usage of medical writing services in review articles in the top 10 highest ranked heme journals in the JCR IF list

[Talha Badar @TalhaBadarMD]

#weekend_review
1/5 Brief overview of venetoclax+azacitidine for elderly #AML ineligible for intensive induction 🧵
#hemoncfellows #hemonctrainees #leusm #MedTwitter
1. Long term outcome from VIALE-A trial
2. Common toxicities and duration of therapy (7 vs 14 vs 28 days)
3. Differential outcome based on molecular signature
4. Venetoclax resistance and outcome post Ven failure

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@docrishabhsingh @OSFHealthCare @UICOMPeoria @UicompP Congratulations!

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@VaqueraH_md Thanks Hector!

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

Officially Board certified Hematologist/Medical Oncologist!!

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

Had a chance to interact with Myeloma Guru, @VincentRK at #ASH24. An incredibly inspiring and humble physician! @ASH_hematology

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

My first ASH Foundation 5K 🏃 in beautiful San Diego #ASH24 @ASH_hematology

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@PavlinaChrysafi @MSKCancerCenter @rushadpatell @LeaderAvi @jzbos Congratulations!!

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@abhishek021196 @CharterCareRI Congratulations!

[Veli Bakalov, MD @HemeOncBuddy]

Fellows tattoo this in your memory!

[Dr. Estela Rodriguez @Latinamd]

🚨Out today #ADRIATIC @NEJM one of the most impactful @ASCO -Lung presentations this year:

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer |
⚡️New standard of care⚡️
N=760
▶️Durvalumab x2 yrs post CRT
⬆️mOS: 56 vs 33mos (HR 0.74)
⬆️mPFS: 16.6 vs 9.2 mos (HR 0.76)

@DavidRSpigel #lcsm

🚨Out today #ADRIATIC @NEJM one of the most impactful @ASCO -Lung presentations this year:

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer |
⚡️New standard of care⚡️
N=760
▶️Durvalumab x2 yrs post CRT
⬆️mOS: 56 vs 33mos (HR 0.74)
⬆️mPFS: 16.6 vs 9.2 mos (HR 0.76)

@DavidRSpigel #lcsm
https://t.co/T5l6vicdt8

[Nico Gagelmann @NicoGagelmann]

Tranfusion reaction algorithm

[Knowuro @knowuro]

Hello #urologists and #oncologists!

Our uro-oncology flowcharts are now available on our website: https://t.co/dvm6yjXInn

Check out our Bladder Cancer Flowchart!
Enjoy! 😃

#BladderCancer #UroOncology #Oncology

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai7]

A young doctor was r@ped & murdered 😭

Doctors are protesting (some aren't!!)

The common man is opposing this protest or simply doesn't care 🤷🏻

The investigation has been botched up 😡

The evidence has been tampered with 😡

How is this acceptable?

#MedTwitter 🇮🇳

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@PamChMD Absolutely true! I can totally relate. It's reassuring to know that these feelings are normal, as @OncBrothers mentioned during ASCO24

[OncoAlert @OncoAlert]

We are @OncoAlert 🚨

[Yashvin Onkarappa Mangala, MD @MDHemeonc]

@NicoGagelmann Chronic lymphocytic leukemia!

I recently saw a patient with CLL on Ibrutinib, whose labs showed a rising WBC count ~600K and a new onset thrombocytosis >1 million.

Review of peripheral blood smear lead to an additional diagnosis!!